NCT07160426View on ClinicalTrials.gov

Study of Protection And Repair of Endothelial-glycocalyx in Sepsis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

October 1, 2027

Conditions
Sepsis
Interventions
BIOLOGICAL

Fresh Frozen Plasma (blood product)

Fresh Frozen Plasma

DRUG

MVI and lactated ringers

placebo

All Listed Sponsors
collaborator

University of Colorado Health

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER